Chance to Get instant and easy money from Bionano Genomics . $1 per share , now it's very low to buy and hold .
More information about the stock . Kindly read and understand and try to do your own analysis about this stock . Thank you
Bionano Genomics (BNGO) Possible Growth Analysis:
Business and Industry: Bionano Genomics is a company operating in the genomics industry, specializing in the development and commercialization of life sciences tools for researchers and clinicians. The genomics industry is experiencing significant growth due to the increasing demand for genetic research and personalized medicine. Bionano Genomics offers innovative solutions that enable the study of structural variations in DNA, providing valuable insights for genetic analysis and diagnosis.
Earnings Forecast: According to the earnings forecast, Bionano Genomics is expected to report a loss per share in the coming years. The forecast for the fiscal year 2025 is a loss of $0.31 per share, improving to a loss of $0.26 per share in 2026. It is important to note that these forecasts are subject to change based on various factors and should be interpreted with caution.
Analyst Recommendations and Target Price: Currently, there are 4 hold recommendations for Bionano Genomics. As for the target price, one analyst forecast suggests a mean, low, and high estimate of $1.0 per share. Please keep in mind that analyst opinions and target prices can vary, and it is essential to conduct your own research and analysis.
Capital Flow: Recent capital flow data shows some fluctuations in Bionano Genomics' stock. It indicates both inflows and outflows of funds in the past few days. Detailed figures on the flow of capital in and out of the stock can be analyzed further for a more comprehensive understanding.
Support and Resistance Price: As of the provided date, the support price for Bionano Genomics is $0.254 per share, while the resistance price is $0.264 per share. These levels can help identify potential buying and selling points for investors.
Recent Earnings Result: The company's financial performance for the third quarter of 2024 shows a negative EPS of $0.52 and a negative return on equity (ROE). Other financial ratios, such as gross profit margin and net profit margin, also indicate negative values. It is essential to consider the company's financial health when evaluating its growth potential.
Stock Price: As of the most recent available date (2025-01-03), the stock price of Bionano Genomics is $0.2553 per share.
It is important to note that investing in stocks carries inherent risks, and the stock market experiences regular fluctuations. The above information should not be considered as investment advice but rather as a summary of the current situation and available data. Investors should conduct their own thorough analysis, consider their risk tolerance, and consult with a qualified financial advisor before making any investment decisions.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
